Search Within

Heather Jolie Landau

Formats
  1. Meeting Abstract (281)
  2. Journal Article (125)
  3. Research Letter (15)
  4. Book Section (5)
  5. Review (3)
  6. Conference Paper (1)
  7. Correspondence (1)
  8. Editorial (1)
  9. Guidelines (1)
Groups
  1. Bone Marrow Transplant (433)
  2. Center for Hematologic Malignancies (433)
  3. Department of Medicine (433)
  4. Hematologic Malignancies, Division of (433)
  5. Survivorship Research (433)
  6. Myeloma (246)

More Groups

People
  1. Sergio Giralt (260)
  2. Hani Hassoun (221)
  3. David Chung (206)
  4. Alexander Lesokhin (184)
  5. Gunjan Shah (161)
  6. Sham Mailankody (144)

More People

Years
  1. 2025 (11)
  2. 2024 (51)
  3. 2023 (48)
  4. 2022 (42)
  5. 2021 (25)
  6. 2020 (34)

More Years

Publications
  1. Blood (154)
  2. Clinical Lymphoma, Myeloma and Leukemia (53)
  3. Biology of Blood and Marrow Transplantation (48)
  4. Journal of Clinical Oncology (24)
  5. Bone Marrow Transplantation (12)
  6. Leukemia and Lymphoma (12)

More Publications

Publishers
  1. American Society of Hematology (165)
  2. Elsevier Inc. (110)
  3. Nature Publishing Group (29)
  4. American Society of Clinical Oncology (25)
  5. Taylor & Francis Group (21)
  6. Ferrata Storti Foundation (8)

More Publishers

Results (433)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Standard-of-care idecabtagene vicleucel for relapsed/refractory multiple myeloma
    Journal Article

    Sidana, S.; Ahmed, N.; Akhtar, O. S.; Brazauskas, R.; Oloyede, T.; Bye, M.; Hansen, D.; Ferreri, C.; Freeman, C. L.; Afrough, A.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies
    Journal Article

    Einarsdottir, S.; Lobaugh, S.; Luan, D.; Gomez-Llobell, M.; Subramanian, P.; Devlin, S.; Chung, D.; Dahi, P. B.; Falchi, L.; Giralt, S.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Restarting teclistamab and talquetamab after prolonged dose delay may not require re–step-up dosing
    Research Letter

    Tan, C. R.; Wang, A.; Nemirovsky, D.; Derkach, A.; Shekarkhand, T.; Hamadeh, I.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • The impact of melphalan conditioning and CD34(+) cell dose and schedule on post-transplant outcomes in AL amyloidosis
    Journal Article

    Muchtar, E.; Sanchorawala, V.; Hassan, H.; Hegenbart, U.; Schönland, S.; Lee, H. C.; Qazilbash, M.; Kin, A.; Zonder, J.; Jacob, E.; more...
    American Journal of Hematology (2025)

    Fulltext@MSK | Save
  • A model for predicting day-100 stem cell transplant-related mortality in AL amyloidosis
    Journal Article

    Muchtar, E.; Dispenzieri, A.; Sanchorawala, V.; Hassan, H.; Mwangi, R.; Maurer, M.; Buadi, F.; Lee, H. C.; Qazilbash, M.; Kin, A.; more...
    Bone Marrow Transplantation (2025)

    Fulltext@MSK | Save
  • Urine-free response criteria predict progression-free survival in multiple myeloma: A post hoc analysis of BMT CTN 0702
    Research Letter

    Banerjee, R.; Fritz, A. R.; Akhtar, O. S.; Freeman, C. L.; Cowan, A. J.; Shah, N.; Landau, H. J.; Kumar, S. K.; Vogl, D. T.; Efebera, Y. A.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Outcomes of older adults and frail patients receiving idecabtagene vicleucel: A CIBMTR study
    Research Letter

    Akhtar, O. S.; Oloyede, T.; Brazauskas, R.; Afrough, A.; Hashmi, H.; Sidana, S.; Ahmed, N.; Bye, M.; Hansen, D.; Ferreri, C.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Health-related values discussions with patients undergoing allogeneic and autologous stem cell transplant: Feasibility and acceptability of an early primary palliative care intervention
    Journal Article

    Cohen, A. G.; Cho, C.; Patterson, E.; Magaldi, J.; Doga, T.; Naputo, K.; Alvarez, K.; Giles, E.; Yang, G.; Hoque, A.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • A pilot study assessing the accuracy of AI ChatGPT responses for AL amyloidosis
    Journal Article

    Saba, L.; Comenzo, R.; Khouri, J.; Anwer, F.; Landau, H.; Chaulagain, C.
    European Journal of Haematology (2025)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor T-cell therapy for multiple myeloma: An updated analysis
    Journal Article

    Jurgens, E. M.; Firestone, R. S.; Chaudhari, J.; Hosszu, K.; Devlin, S. M.; Shah, U. A.; Landa, J.; McAvoy, D. P.; Lesokhin, A. M.; Korde, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save